APL

APL (Apotek Produktion & Laboratorier) develops, analyses and manufactures extemporaneous and stock-batch medicines, and supplies licensed medicines for Swedish healthcare. Its contract development and manufacturing (CDMO) services cover formulation development, analytical method development, stability studies, clinical trial material and commercial production. The company also states it uses 3D-printing technology for automated medicine dispensing.

Its customers include healthcare and pharmacy professionals who order extemporaneous medicines through the EbEx ordering system or by email and phone, and life science companies that use its CDMO services. The website describes APL as a state-owned company with a public-service mission to provide a quality-assured range of extemporaneous medicines, secure access to licensed medicines, and maintain operations during emergency preparedness situations.

The website lists customer service in Sweden (phone 010-447 97 00) and does not state a founding year or headquarters city. The company's open role in the job feed is a production manager (Tillverkningschef) based in Stockholm.

Product: Extemporaneous and stock-batch medicines, licensed medicines supply, and CDMO services (formulation, analytics, stability studies, clinical trial material, commercial manufacturing).